Is routine AFP screening in pregnancy reassuring?

Area of Science:

• Prenatal diagnostics
• Maternal-fetal medicine
• Genetics

Background:

• Routine prenatal screening tests, such as maternal serum alpha-fetoprotein (MSAFP) screening, are commonly used to assess fetal health.
• These tests screen for conditions like spina bifida and Down's syndrome.
• Understanding the psychological impact of screening results on expectant mothers is crucial for effective patient care.

Purpose of the Study:

• To investigate the impact of a negative result from maternal serum alpha-fetoprotein (MSAFP) screening on maternal anxiety and concerns.
• To determine if a negative screening result provides reassurance regarding the baby's health.
• To explore potential reasons why negative results may not offer reassurance.

Main Methods:

• A study involving 309 women who underwent MSAFP screening and 30 women who did not.
• Assessment of four groups: those tested and received negative results, those tested but unaware, those not tested but believed they were, and those not tested and aware.
• Measurement of anxiety, certainty about baby's health, and worry about baby's health across groups.

Main Results:

• No significant differences in anxiety levels, certainty about the baby's health, or worry about the baby's health were found between the four groups.
• The receipt of a negative MSAFP screening result did not appear to provide reassurance to the majority of women.
• Discrepancies in awareness of having been tested were noted.

Conclusions:

• Negative results from MSAFP screening may not offer the expected reassurance to expectant mothers.
• Potential explanations include lack of knowledge about negative result interpretation or ineffective communication of results.
• Enhanced communication strategies regarding prenatal screening results could improve their reassuring effect.